“This year’s Calicivirus Conference will bring together the world's leading norovirus experts, making it the ideal venue to share our pan-viral protease inhibitor CDI-988 Phase 1 data and ...

“This year's Calicivirus Conference will bring together the world's leading norovirus experts, making it the ideal venue to share our pan-viral protease inhibitor CDI-988 Phase 1 data and ...

BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral ...

About the Calicivirus Conference The International Calicivirus Conference is held every three years and unites scientists from across the globe who study calicivirus virology, evolution, pathogenesis, ...

An announcement from Cocrystal Pharma ( ($COCP) ) is now available. Cocrystal Pharma announced on July 10, 2025, that its broad-spectrum protease ...

Both were born to a stray named Kitty Kat and survived Parvovirus, a disease with a 95% fatality rate in kittens. Out of five ...

Having a sick cat can be incredibly stressful. A trip to the vet is never cheap, and they will probably need to draw blood, ...

Otis had most of his teeth extracted due to the gums growing over them, and now he resembles a real-life emoji with his tongue sticking out.

A free pet wellness clinic offering vaccines and microchips will be held June 28 in East Cleveland for Cleveland and East Cleveland residents.

Perinton, N.Y. — Lollypop Farm is providing free resources to pet parents. Free vaccines for cats and dogs will be available this Wednesday at one of the farm's community pet care events, which ...

Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus ConferenceBOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) ...

“This year’s Calicivirus Conference will bring together the world's leading norovirus experts, making it the ideal venue to share our pan-viral protease inhibitor CDI-988 Phase 1 data and clinical ...